Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Evan Secor

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Current Opinion in HIV and AIDS|February 14, 2012
The effects of schistosomiasis on HIV/AIDS infection, progression and transmissionW Evan Secor
F1000Research|March 4, 2016
Early lessons from schistosomiasis mass drug administration programsW Evan Secor
Current Opinion in Infectious Diseases|September 1, 2007
Below the belt: new insights into potential complications of HIV-1/schistosome coinfectionsW Evan Secor, J Bruce Sundstrom
Parasitology International|April 15, 2004
Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?Daniel G Colley, W Evan Secor
Sexually Transmitted Infections|June 25, 2013
Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolatesE Brook Goodhew, W Evan Secor
Plos Neglected Tropical Diseases|December 7, 2007
A schistosomiasis research agendaDaniel G Colley, W Evan Secor
Current Opinion in Infectious Diseases|July 8, 2011
Schistosomiasis: from drug deployment to drug developmentConor R Caffrey, W Evan Secor
Tropical Medicine and Infectious Disease|October 3, 2018
When Should the Emphasis on Schistosomiasis Control Move to Elimination?W Evan Secor, Daniel G Colley
Parasitology Research|July 24, 2010
Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United StatesSara E Butler, Peter Augostini, W Evan Secor
Trends in Parasitology|February 19, 2013
Infection and treatment immunizations for successful parasite vaccinesFrancisca Mutapi, Peter F Billingsley, W Evan Secor
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Current Opinion in HIV and AIDS|February 14, 2012
The effects of schistosomiasis on HIV/AIDS infection, progression and transmissionW Evan Secor
F1000Research|March 4, 2016
Early lessons from schistosomiasis mass drug administration programsW Evan Secor
Current Opinion in Infectious Diseases|September 1, 2007
Below the belt: new insights into potential complications of HIV-1/schistosome coinfectionsW Evan Secor, J Bruce Sundstrom
Parasitology International|April 15, 2004
Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?Daniel G Colley, W Evan Secor
Sexually Transmitted Infections|June 25, 2013
Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolatesE Brook Goodhew, W Evan Secor
Plos Neglected Tropical Diseases|December 7, 2007
A schistosomiasis research agendaDaniel G Colley, W Evan Secor
Current Opinion in Infectious Diseases|July 8, 2011
Schistosomiasis: from drug deployment to drug developmentConor R Caffrey, W Evan Secor
Tropical Medicine and Infectious Disease|October 3, 2018
When Should the Emphasis on Schistosomiasis Control Move to Elimination?W Evan Secor, Daniel G Colley
Parasitology Research|July 24, 2010
Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United StatesSara E Butler, Peter Augostini, W Evan Secor
Trends in Parasitology|February 19, 2013
Infection and treatment immunizations for successful parasite vaccinesFrancisca Mutapi, Peter F Billingsley, W Evan Secor
Pageof 13